ID   RBBP6_HUMAN             Reviewed;        1792 AA.
AC   Q7Z6E9; Q147T5; Q15290; Q6DKH4; Q6P4C2; Q6YNC9; Q7Z6E8; Q8N0V2;
AC   Q96PH3; Q9H3I8; Q9H5M5; Q9NPX4;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=E3 ubiquitin-protein ligase RBBP6;
DE            EC=2.3.2.27;
DE   AltName: Full=Proliferation potential-related protein;
DE   AltName: Full=Protein P2P-R;
DE   AltName: Full=RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};
DE   AltName: Full=Retinoblastoma-binding Q protein 1;
DE            Short=RBQ-1;
DE   AltName: Full=Retinoblastoma-binding protein 6;
DE   AltName: Full=p53-associated cellular protein of testis;
GN   Name=RBBP6; Synonyms=P2PR, PACT, RBQ1; ORFNames=My038;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Kudo E., Itakura M.;
RT   "Retinoblastoma binding protein 6 (RBBP6), mRNA.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-1727 (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1427-1792 (ISOFORMS 1/2/4).
RC   TISSUE=Bone, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-55 (ISOFORMS 1/2/3/4).
RC   TISSUE=Fetal brain;
RA   Mao Y.M., Xie Y., Zheng Z.H.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-1792 (ISOFORM 2).
RC   TISSUE=Spleen;
RA   Ma X., Qu X., Sun L., Wu S., He F.;
RT   "The cDNA sequence for the human PACT gene.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-1792 (ISOFORM 1).
RA   Camargo A.A., Moreira E.S., Simpson A.J.G.;
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-1146 (ISOFORM 1).
RC   TISSUE=Lung carcinoma;
RX   PubMed=8595913; DOI=10.1006/geno.1995.0017;
RA   Sakai Y., Saijo M., Coelho K., Kishino T., Niikawa N., Taya Y.;
RT   "cDNA sequence and chromosomal localization of a novel human protein,
RT   RBQ-1 (RBBP6), that binds to the retinoblastoma gene product.";
RL   Genomics 30:98-101(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1165-1792 (ISOFORMS 1/2).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1264-1792 (ISOFORMS 1/2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12064457; DOI=10.1002/jcp.10084;
RA   Gao S., Witte M.M., Scott R.E.;
RT   "P2P-R protein localizes to the nucleolus of interphase cells and the
RT   periphery of chromosomes in mitotic cells which show maximum P2P-R
RT   immunoreactivity.";
RL   J. Cell. Physiol. 191:145-154(2002).
RN   [11]
RP   ERRATUM.
RA   Gao S., Witte M.M., Scott R.E.;
RL   J. Cell. Physiol. 192:359-360(2002).
RN   [12]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND OVEREXPRESSION IN
RP   ESOPHAGEAL CANCER.
RX   PubMed=15475430; DOI=10.1158/1078-0432.CCR-04-0841;
RA   Yoshitake Y., Nakatsura T., Monji M., Senju S., Matsuyoshi H.,
RA   Tsukamoto H., Hosaka S., Komori H., Fukuma D., Ikuta Y., Katagiri T.,
RA   Furukawa Y., Ito H., Shinohara M., Nakamura Y., Nishimura Y.;
RT   "Proliferation potential-related protein, an ideal esophageal cancer
RT   antigen for immunotherapy, identified using complementary DNA
RT   microarray analysis.";
RL   Clin. Cancer Res. 10:6437-6448(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246;
RP   SER-247; SER-360; SER-770; SER-772; SER-861; SER-1179 AND SER-1328,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   INTERACTION WITH MDM2.
RX   PubMed=17470788; DOI=10.1073/pnas.0701916104;
RA   Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., Yin X., Yang J.,
RA   Gao X., Zhu Y., Sun Q., Zhang L., Yang X., He F.;
RT   "PACT is a negative regulator of p53 and essential for cell growth and
RT   embryonic development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:7951-7956(2007).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH YBX1.
RX   PubMed=18851979; DOI=10.1016/j.jmb.2008.09.060;
RA   Chibi M., Meyer M., Skepu A., Rees D.J.G., Moolman-Smook J.C.,
RA   Pugh D.J.;
RT   "RBBP6 interacts with multifunctional protein YB-1 through its RING
RT   finger domain, leading to ubiquitination and proteosomal degradation
RT   of YB-1.";
RL   J. Mol. Biol. 384:908-916(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-1179;
RP   THR-1468; SER-1646 AND SER-1648, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1328, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516; SER-1179; SER-1277;
RP   SER-1328 AND SER-1648, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   SUBCELLULAR LOCATION, INTERACTION WITH NEK6, AND PHOSPHORYLATION.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C.,
RA   Santana Bernachi J., Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for
RT   its short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246;
RP   SER-247; SER-516; SER-861; SER-1179 AND SER-1328, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780; SER-1179 AND
RP   SER-1328, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-768;
RP   SER-770; SER-772; SER-815; SER-861; SER-873; SER-957; THR-984;
RP   SER-1179; SER-1221; SER-1277; SER-1328; SER-1341 AND SER-1347, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH ZBTB38.
RX   PubMed=24726359; DOI=10.1016/j.celrep.2014.03.030;
RA   Miotto B., Chibi M., Xie P., Koundrioukoff S., Moolman-Smook H.,
RA   Pugh D., Debatisse M., He F., Zhang L., Defossez P.A.;
RT   "The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common
RT   fragile site stability.";
RL   Cell Rep. 7:575-587(2014).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-984 AND SER-1277, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1106 AND LYS-1169, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [29]
RP   STRUCTURE BY NMR OF 1-81.
RX   PubMed=16396680; DOI=10.1186/1472-6807-6-1;
RA   Pugh D.J.R., Ab E., Faro A., Lutya P.T., Hoffmann E., Rees D.J.G.;
RT   "DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA
RT   processing and ubiquitin-like pathways.";
RL   BMC Struct. Biol. 6:1-1(2006).
RN   [30]
RP   STRUCTURE BY NMR OF 159-309.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the zinc finger CCHC domain and of the RING
RT   finger from the human retinoblastoma-binding protein 6
RT   (retinoblastoma-binding Q protein 1, RBQ-1).";
RL   Submitted (APR-2008) to the PDB data bank.
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which promotes
CC       ubiquitination of YBX1, leading to its degradation by the
CC       proteasome (PubMed:18851979). May play a role as a scaffold
CC       protein to promote the assembly of the p53/TP53-MDM2 complex,
CC       resulting in increase of MDM2-mediated ubiquitination and
CC       degradation of p53/TP53; may function as negative regulator of
CC       p53/TP53, leading to both apoptosis and cell growth (By
CC       similarity). Regulates DNA-replication and the stability of
CC       chromosomal common fragile sites (CFSs) in a ZBTB38- and MCM10-
CC       dependent manner. Controls ZBTB38 protein stability and abundance
CC       via ubiquitination and proteasomal degradation, and ZBTB38 in turn
CC       negatively regulates the expression of MCM10 which plays an
CC       important role in DNA-replication (PubMed:24726359).
CC       {ECO:0000250|UniProtKB:P97868, ECO:0000269|PubMed:18851979,
CC       ECO:0000269|PubMed:24726359}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with p53/TP53 and RB1 (By similarity).
CC       Interacts also with MDM2 and YBX1. Interacts with NEK6. Interacts
CC       with ZBTB38. {ECO:0000250|UniProtKB:P97868,
CC       ECO:0000269|PubMed:17470788, ECO:0000269|PubMed:18851979,
CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:24726359}.
CC   -!- INTERACTION:
CC       Q16629:SRSF7; NbExp=3; IntAct=EBI-2117026, EBI-398885;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome.
CC       Note=Colocalizes with mitotic chromosomes. Colocalizes with NEK6
CC       in the centrosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q7Z6E9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z6E9-2; Sequence=VSP_018284;
CC       Name=3;
CC         IsoId=Q7Z6E9-3; Sequence=VSP_018281, VSP_018282;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q7Z6E9-4; Sequence=VSP_018283;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the placenta and testis.
CC       Expressed at lower levels in the brain, heart, kidney, liver and
CC       lung. Overexpressed in esophageal cancer.
CC       {ECO:0000269|PubMed:15475430}.
CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000269|PubMed:20873783}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG43155.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=AAH63524.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAL05625.1; Type=Frameshift; Positions=198; Evidence={ECO:0000305};
CC       Sequence=AAL68925.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=CAA59445.1; Type=Frameshift; Positions=198, 1048, 1098; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB112074; BAC77636.1; -; mRNA.
DR   EMBL; AB112075; BAC77637.1; -; mRNA.
DR   EMBL; CH471145; EAW55789.1; -; Genomic_DNA.
DR   EMBL; BC029352; AAH29352.1; -; mRNA.
DR   EMBL; BC063524; AAH63524.1; ALT_SEQ; mRNA.
DR   EMBL; BC073938; AAH73938.1; -; mRNA.
DR   EMBL; BC101139; AAI01140.1; -; mRNA.
DR   EMBL; BC101140; AAI01141.1; -; mRNA.
DR   EMBL; BC101141; AAI01142.1; -; mRNA.
DR   EMBL; BC101142; AAI01143.1; -; mRNA.
DR   EMBL; BC114353; AAI14354.1; -; mRNA.
DR   EMBL; BC114354; AAI14355.1; -; mRNA.
DR   EMBL; BC118667; AAI18668.1; -; mRNA.
DR   EMBL; BC139830; AAI39831.1; -; mRNA.
DR   EMBL; AF063596; AAG43155.1; ALT_SEQ; mRNA.
DR   EMBL; AY072922; AAL68925.1; ALT_SEQ; mRNA.
DR   EMBL; AF352051; AAL05625.1; ALT_FRAME; mRNA.
DR   EMBL; X85133; CAA59445.1; ALT_FRAME; mRNA.
DR   EMBL; AK026954; BAB15600.1; -; mRNA.
DR   EMBL; AL359564; CAB94869.1; -; mRNA.
DR   CCDS; CCDS10621.1; -. [Q7Z6E9-1]
DR   CCDS; CCDS10622.1; -. [Q7Z6E9-2]
DR   CCDS; CCDS45444.1; -. [Q7Z6E9-3]
DR   PIR; A57640; A57640.
DR   PIR; T50609; T50609.
DR   RefSeq; NP_008841.2; NM_006910.4. [Q7Z6E9-1]
DR   RefSeq; NP_061173.1; NM_018703.3. [Q7Z6E9-2]
DR   RefSeq; NP_116015.2; NM_032626.5. [Q7Z6E9-3]
DR   UniGene; Hs.188553; -.
DR   PDB; 2C7H; NMR; -; A=1-81.
DR   PDB; 2YSA; NMR; -; A=159-206.
DR   PDB; 2YUR; NMR; -; A=249-309.
DR   PDB; 3ZTG; NMR; -; A/B=249-335.
DR   PDBsum; 2C7H; -.
DR   PDBsum; 2YSA; -.
DR   PDBsum; 2YUR; -.
DR   PDBsum; 3ZTG; -.
DR   ProteinModelPortal; Q7Z6E9; -.
DR   SMR; Q7Z6E9; -.
DR   BioGrid; 111865; 92.
DR   DIP; DIP-46897N; -.
DR   IntAct; Q7Z6E9; 36.
DR   MINT; MINT-1181085; -.
DR   STRING; 9606.ENSP00000317872; -.
DR   iPTMnet; Q7Z6E9; -.
DR   PhosphoSitePlus; Q7Z6E9; -.
DR   BioMuta; RBBP6; -.
DR   DMDM; 74762440; -.
DR   EPD; Q7Z6E9; -.
DR   MaxQB; Q7Z6E9; -.
DR   PaxDb; Q7Z6E9; -.
DR   PeptideAtlas; Q7Z6E9; -.
DR   PRIDE; Q7Z6E9; -.
DR   DNASU; 5930; -.
DR   Ensembl; ENST00000319715; ENSP00000317872; ENSG00000122257. [Q7Z6E9-1]
DR   Ensembl; ENST00000348022; ENSP00000316291; ENSG00000122257. [Q7Z6E9-2]
DR   Ensembl; ENST00000381039; ENSP00000370427; ENSG00000122257. [Q7Z6E9-4]
DR   Ensembl; ENST00000452655; ENSP00000390537; ENSG00000122257. [Q7Z6E9-3]
DR   GeneID; 5930; -.
DR   KEGG; hsa:5930; -.
DR   UCSC; uc002dmg.4; human. [Q7Z6E9-1]
DR   CTD; 5930; -.
DR   DisGeNET; 5930; -.
DR   GeneCards; RBBP6; -.
DR   HGNC; HGNC:9889; RBBP6.
DR   HPA; CAB032866; -.
DR   HPA; HPA041725; -.
DR   HPA; HPA043544; -.
DR   MIM; 600938; gene.
DR   neXtProt; NX_Q7Z6E9; -.
DR   OpenTargets; ENSG00000122257; -.
DR   PharmGKB; PA34253; -.
DR   eggNOG; KOG0314; Eukaryota.
DR   eggNOG; COG5222; LUCA.
DR   GeneTree; ENSGT00610000086096; -.
DR   HOVERGEN; HBG061131; -.
DR   InParanoid; Q7Z6E9; -.
DR   KO; K10624; -.
DR   OMA; KERYREW; -.
DR   OrthoDB; EOG091G09Q6; -.
DR   PhylomeDB; Q7Z6E9; -.
DR   TreeFam; TF350543; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RBBP6; human.
DR   EvolutionaryTrace; Q7Z6E9; -.
DR   GeneWiki; RBBP6; -.
DR   GenomeRNAi; 5930; -.
DR   PMAP-CutDB; Q7Z6E9; -.
DR   PRO; PR:Q7Z6E9; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000122257; -.
DR   ExpressionAtlas; Q7Z6E9; baseline and differential.
DR   Genevisible; Q7Z6E9; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IMP:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0048568; P:embryonic organ development; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0006275; P:regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:0061053; P:somite development; IEA:Ensembl.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 4.10.60.10; -; 1.
DR   InterPro; IPR014891; DWNN_domain.
DR   InterPro; IPR033489; RBBP6.
DR   InterPro; IPR003613; Ubox_domain.
DR   InterPro; IPR025829; Zn_knuckle_CX2CX3GHX4C.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR15439:SF14; PTHR15439:SF14; 1.
DR   Pfam; PF08783; DWNN; 1.
DR   Pfam; PF04564; U-box; 1.
DR   Pfam; PF13696; zf-CCHC_2; 1.
DR   SMART; SM01180; DWNN; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00343; ZnF_C2HC; 1.
DR   SUPFAM; SSF57756; SSF57756; 1.
DR   PROSITE; PS51282; DWNN; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosome;
KW   Complete proteome; Cytoplasm; Cytoskeleton; DNA damage;
KW   DNA replication; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1792       E3 ubiquitin-protein ligase RBBP6.
FT                                /FTId=PRO_0000234354.
FT   DOMAIN        4     76       DWNN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00612}.
FT   ZN_FING     159    176       CCHC-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING     259    300       RING-type; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   REGION      982   1139       Interaction with RB1. {ECO:0000250}.
FT   REGION     1433   1544       Interaction with p53. {ECO:0000250}.
FT   MOD_RES     130    130       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P97868}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     245    245       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     246    246       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     247    247       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     360    360       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     516    516       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     768    768       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     770    770       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     772    772       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     780    780       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     815    815       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     861    861       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     873    873       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     957    957       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     984    984       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1179   1179       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1221   1221       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1271   1271       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97868}.
FT   MOD_RES    1277   1277       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1328   1328       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1341   1341       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1347   1347       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1468   1468       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1646   1646       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1648   1648       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1651   1651       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97868}.
FT   CROSSLNK   1106   1106       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297}.
FT   CROSSLNK   1169   1169       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297}.
FT   VAR_SEQ     102    117       IDDSSASISLAQLTKT -> VCKNTISHFFYTLLLPL (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018281.
FT   VAR_SEQ     118   1792       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018282.
FT   VAR_SEQ     431   1270       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018283.
FT   VAR_SEQ     652    685       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.1, ECO:0000303|Ref.5}.
FT                                /FTId=VSP_018284.
FT   VARIANT      43     43       D -> H (in dbSNP:rs16973796).
FT                                /FTId=VAR_051306.
FT   VARIANT     555    555       V -> A (in dbSNP:rs16973840).
FT                                /FTId=VAR_026216.
FT   VARIANT    1208   1208       K -> I (in dbSNP:rs3743968).
FT                                /FTId=VAR_051307.
FT   CONFLICT    223    223       I -> T (in Ref. 5; AAL68925).
FT                                {ECO:0000305}.
FT   CONFLICT   1633   1633       D -> H (in Ref. 5; AAL68925).
FT                                {ECO:0000305}.
FT   STRAND        1      8       {ECO:0000244|PDB:2C7H}.
FT   STRAND       12     25       {ECO:0000244|PDB:2C7H}.
FT   HELIX        26     37       {ECO:0000244|PDB:2C7H}.
FT   TURN         41     43       {ECO:0000244|PDB:2C7H}.
FT   STRAND       44     53       {ECO:0000244|PDB:2C7H}.
FT   STRAND       63     65       {ECO:0000244|PDB:2C7H}.
FT   STRAND       70     76       {ECO:0000244|PDB:2C7H}.
FT   TURN        162    164       {ECO:0000244|PDB:2YSA}.
FT   HELIX       171    173       {ECO:0000244|PDB:2YSA}.
FT   HELIX       176    178       {ECO:0000244|PDB:2YSA}.
FT   STRAND      197    199       {ECO:0000244|PDB:2YSA}.
FT   HELIX       255    257       {ECO:0000244|PDB:2YUR}.
FT   STRAND      260    262       {ECO:0000244|PDB:2YUR}.
FT   STRAND      273    275       {ECO:0000244|PDB:2YUR}.
FT   HELIX       283    290       {ECO:0000244|PDB:2YUR}.
FT   STRAND      291    294       {ECO:0000244|PDB:2YUR}.
FT   STRAND      297    299       {ECO:0000244|PDB:2YUR}.
FT   TURN        306    309       {ECO:0000244|PDB:2YUR}.
FT   HELIX       313    326       {ECO:0000244|PDB:3ZTG}.
SQ   SEQUENCE   1792 AA;  201564 MW;  550F7BBA5125DA06 CRC64;
     MSCVHYKFSS KLNYDTVTFD GLHISLCDLK KQIMGREKLK AADCDLQITN AQTKEEYTDD
     NALIPKNSSV IVRRIPIGGV KSTSKTYVIS RTEPAMATTK AIDDSSASIS LAQLTKTANL
     AEANASEEDK IKAMMSQSGH EYDPINYMKK PLGPPPPSYT CFRCGKPGHY IKNCPTNGDK
     NFESGPRIKK STGIPRSFMM EVKDPNMKGA MLTNTGKYAI PTIDAEAYAI GKKEKPPFLP
     EEPSSSSEED DPIPDELLCL ICKDIMTDAV VIPCCGNSYC DECIRTALLE SDEHTCPTCH
     QNDVSPDALI ANKFLRQAVN NFKNETGYTK RLRKQLPPPP PPIPPPRPLI QRNLQPLMRS
     PISRQQDPLM IPVTSSSTHP APSISSLTSN QSSLAPPVSG NPSSAPAPVP DITATVSISV
     HSEKSDGPFR DSDNKILPAA ALASEHSKGT SSIAITALME EKGYQVPVLG TPSLLGQSLL
     HGQLIPTTGP VRINTARPGG GRPGWEHSNK LGYLVSPPQQ IRRGERSCYR SINRGRHHSE
     RSQRTQGPSL PATPVFVPVP PPPLYPPPPH TLPLPPGVPP PQFSPQFPPG QPPPAGYSVP
     PPGFPPAPAN LSTPWVSSGV QTAHSNTIPT TQAPPLSREE FYREQRRLKE EEKKKSKLDE
     FTNDFAKELM EYKKIQKERR RSFSRSKSPY SGSSYSRSSY TYSKSRSGST RSRSYSRSFS
     RSHSRSYSRS PPYPRRGRGK SRNYRSRSRS HGYHRSRSRS PPYRRYHSRS RSPQAFRGQS
     PNKRNVPQGE TEREYFNRYR EVPPPYDMKA YYGRSVDFRD PFEKERYREW ERKYREWYEK
     YYKGYAAGAQ PRPSANRENF SPERFLPLNI RNSPFTRGRR EDYVGGQSHR SRNIGSNYPE
     KLSARDGHNQ KDNTKSKEKE SENAPGDGKG NKHKKHRKRR KGEESEGFLN PELLETSRKS
     REPTGVEENK TDSLFVLPSR DDATPVRDEP MDAESITFKS VSEKDKRERD KPKAKGDKTK
     RKNDGSAVSK KENIVKPAKG PQEKVDGERE RSPRSEPPIK KAKEETPKTD NTKSSSSSQK
     DEKITGTPRK AHSKSAKEHQ ETKPVKEEKV KKDYSKDVKS EKLTTKEEKA KKPNEKNKPL
     DNKGEKRKRK TEEKGVDKDF ESSSMKISKL EVTEIVKPSP KRKMEPDTEK MDRTPEKDKI
     SLSAPAKKIK LNRETGKKIG STENISNTKE PSEKLESTSS KVKQEKVKGK VRRKVTGTEG
     SSSTLVDYTS TSSTGGSPVR KSEEKTDTKR TVIKTMEEYN NDNTAPAEDV IIMIQVPQSK
     WDKDDFESEE EDVKSTQPIS SVGKPASVIK NVSTKPSNIV KYPEKESEPS EKIQKFTKDV
     SHEIIQHEVK SSKNSASSEK GKTKDRDYSV LEKENPEKRK NSTQPEKESN LDRLNEQGNF
     KSLSQSSKEA RTSDKHDSTR ASSNKDFTPN RDKKTDYDTR EYSSSKRRDE KNELTRRKDS
     PSRNKDSASG QKNKPREERD LPKKGTGDSK KSNSSPSRDR KPHDHKATYD TKRPNEETKS
     VDKNPCKDRE KHVLEARNNK ESSGNKLLYI LNPPETQVEK EQITGQIDKS TVKPKPQLSH
     SSRLSSDLTR ETDEAAFEPD YNESDSESNV SVKEEESSGN ISKDLKDKIV EKAKESLDTA
     AVVQVGISRN QSHSSPSVSP SRSHSPSGSQ TRSHSSSASS AESQDSKKKK KKKEKKKHKK
     HKKHKKHKKH AGTEVELEKS QKHKHKKKKS KKNKDKEKEK EKDDQKVKSV TV
//
